| 000 | a | ||
|---|---|---|---|
| 999 |
_c9634 _d9634 |
||
| 003 | OSt | ||
| 005 | 20191009100934.0 | ||
| 008 | 191009b xxu||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_99780 _aJain, R. Ashish |
||
| 245 | _aNewer potential pharmacological targets for autism spectrum disorder | ||
| 250 | _aVol.51(4), July-Aug | ||
| 260 |
_aMumbai _bWolter Kluwer _c2019 |
||
| 300 | _a284-286p. | ||
| 520 | _aAutism is a cluster of heterogeneous disorders which are neurodevelopmental and are distinctive by initial difficulties in social life, communication among individuals, restrictive/repetitive behavior, and interests. The pathophysiology behind autism is still complex, and no single etiological and pathophysiological mechanism is involved. There are many different etiologies behind autism spectrum disorder (ASD) | ||
| 650 | 0 |
_94774 _aPHARMACOLOGY |
|
| 700 |
_97681 _aAjay Prakash |
||
| 773 | 0 |
_tIndian Journal of Pharmacology _dAndheri - Mumbai Wolters Kluwer India Private Limited _x0253-7613 |
|
| 856 |
_uhttp://www.ijp-online.com/temp/IndianJPharmacol514284-1809362_003009.pdf _yClick here |
||
| 942 |
_2ddc _cAR |
||